Royal Bank of Canada
ENVB icon

Royal Bank of Canada’s Enveric Biosciences ENVB Stock Holding History

Royal Bank of Canada’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$1K – 7204
2023
Q2 		$1K Hold
1
– – ﹤0.01% 6991
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7163
2022
Q4 		$0 Hold
1
– – ﹤0.01% 7347
2022
Q3 		$1K Hold
1
– – ﹤0.01% 7176
2022
Q2 		$2K Buy
+1
New +$2.13K ﹤0.01% 6940
2022
Q1 		– Hold
0
– – – 7805
2020
Q3 		– Hold
0
– -$2K – 6701
2020
Q2 		– Hold
0
– – – 6275
2020
Q1 		– Hold
0
– – – 6749
2019
Q4 		– Hold
0
– – – 6644
2019
Q3 		– Hold
0
– – – 6433

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada's ENVB Position: Q3 2023 in Review

Royal Bank of Canada sold out of Enveric Biosciences (ENVB) in Q3 2023, closing a stake of 1 share — an estimated $1K sold.

Royal Bank of Canada first reported a position in ENVB in Q2 2022 and held it in 5 quarters. The position peaked at $2K in Q2 2022. 10 funds tracked by Wall St. Rank hold ENVB as of Q3 2023.

  • Royal Bank of Canada reported no remaining Enveric Biosciences position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 1 Enveric Biosciences share in Q3 2023, an estimated $1K.
  • Royal Bank of Canada first reported a position in Enveric Biosciences in Q2 2022 and held it in 5 quarters.
  • Royal Bank of Canada's Enveric Biosciences position peaked at $2K in Q2 2022.
  • 10 funds tracked by Wall St. Rank held Enveric Biosciences as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.